VERAXA Biotech Launches on Nasdaq to Develop Cancer Therapies

VERAXA Biotech 在納斯達克上市，致力於開發癌症療法

更新於: 2026年6月11日 下午01:05

On June 11, 2026, Zurich-based biopharmaceutical company VERAXA Biotech AG officially reached a major milestone by launching on the Nasdaq Capital Market.

2026年6月11日，總部位於蘇黎世的生物製藥公司VERAXA Biotech AG正式達成了一個重要的里程碑，在納斯達克資本市場掛牌上市。

nounJune 11, 2026
nounVERAXA Biotech AG
nounNasdaq Capital Market

Following this merger, the firm now trades under the ticker symbol 'VRXA.'

進行業務合併，實現了公開上市的地位。

nounmerger

VERAXA specializes in developing advanced cancer therapies, specifically utilizing its proprietary BiTAC platform.

此次轉型對生物技術領域而言是一個重要時刻，為該公司提供了7750萬美元的新資金以推動其發展。

verbdevelop
nouncancer

This technology aims to create 'AND-gated' treatments that specifically identify and attack cancer cells while leaving healthy tissue unharmed.

VERAXA專門開發先進的癌症療法，特別是利用其專有的BiTAC平台。

nouncancer

As Chairman Oliver R.

VERAXA的研究源自歐洲分子生物學實驗室，如今已做好充分準備，加速其腫瘤學產品管線的臨床試驗。

nounchairman

Baumann noted, this Nasdaq listing is a pivotal step in scaling their innovative technology and bringing next-generation cancer solutions to patients globally.

正如董事長Oliver R.

adjectiveinnovative
nouncancer
🎉

文章閱讀結束

你閱讀了 6 句重點內容。

挑戰模式

閱讀理解

On what date did VERAXA Biotech AG become a publicly traded company on Nasdaq?

✓

正確答案

June 11, 2026

What is the primary function of VERAXA's proprietary BiTAC platform?

✓

正確答案

To create conditionally activated therapies that target cancer cells while sparing healthy tissue

How did VERAXA Biotech AG enter the public stock market?

✓

正確答案

By completing a business combination with Voyager Acquisition Corp.

What is the ticker symbol for VERAXA Biotech AG common stock on the Nasdaq?

✓

正確答案

VRXA

What is the primary goal for the $77.5 million raised by VERAXA?

✓

正確答案

To accelerate the development of oncology drug candidates and clinical programs

Ringoo Icon

使用 Ringoo App 學習更快速

追蹤你的學習進度，並透過互動式練習獲得即時回饋。

App StoreGoogle Play